{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:25:43Z","timestamp":1740147943423,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11926-021-01026-6","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T15:03:20Z","timestamp":1625324600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Familial Clustering of Juvenile Psoriatic Arthritis Associated with a Hemizygous FOXP3 Mutation"],"prefix":"10.1007","volume":"23","author":[{"given":"Raed","family":"Alzyoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahad","family":"Alansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Maaitah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haya","family":"AlDossari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Monies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-6698","authenticated-orcid":false,"given":"Sulaiman M","family":"Al-Mayouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"key":"1026_CR1","first-page":"390","volume":"31","author":"R Petty","year":"2001","unstructured":"Petty R, Southwood T, Manners P, Baum J, Glass D, Goldenberg J, et al. International League of Association of Rheumatology of juvenile idiopathic arthritis: second revision, Edmonton. J Rheumatol. 2001;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"1026_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fped.2019.00353","volume":"7","author":"O Delmonte","year":"2019","unstructured":"Delmonte O, Castagnoli R, Calzoni E, Notarangelo L. Inborn errors of immunity with immune dysregulation: from bench to bedside. Front Pediatr. 2019;7:353. https:\/\/doi.org\/10.3389\/fped.2019.00353.","journal-title":"Front Pediatr"},{"issue":"5","key":"1026_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/BOR.0000000000000207","volume":"27","author":"A de Jesus","year":"2015","unstructured":"de Jesus A, Goldbach-Mansky R. Newly recognized Mendelian disorders with rheumatic manifestations. Curr Opin Rheumatol. 2015;27(5):511\u20139. https:\/\/doi.org\/10.1097\/BOR.0000000000000207.","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"1026_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s10875-016-0330-1","volume":"36","author":"\u0160 Blazina","year":"2016","unstructured":"Blazina \u0160, Markelj G, Jeverica A, Toplak N, Bratani\u010d N, Jazbec J, et al. Autoimmune and inflammatory manifestations in 247 patients with primary immunodeficiency-a report from the Slovenian National Registry. J Clin Immunol. 2016;36(8):764\u201373. https:\/\/doi.org\/10.1007\/s10875-016-0330-1.","journal-title":"J Clin Immunol"},{"key":"1026_CR5","doi-asserted-by":"publisher","unstructured":"Bacchetta R, Barzaghi F, Roncarolo M. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci. 2018;1417:5\u201322. https:\/\/doi.org\/10.1111\/nyas.13011. This article reviews the current knowledge about IPEX syndrome and highlight findings that could lead to novel targeted treatments.","DOI":"10.1111\/nyas.13011"},{"key":"1026_CR6","doi-asserted-by":"publisher","unstructured":"Huang Q, Liu X, Zhang Y, Huang J, Li D, Li B. Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy. X-linked syndrome J Genet Genomics. 2020;47:17\u201326. https:\/\/doi.org\/10.1016\/j.jgg.2019.11.011. This article reviews the current knowledge about the underlying mechanism of FOXP3 mutant-induced IPEX syndrome and some latest clinical prospects; and review offers a novel insight into the role played by the FOXP3 complex in potential therapeutic applications in IPEX syndrome.","DOI":"10.1016\/j.jgg.2019.11.011"},{"key":"1026_CR7","doi-asserted-by":"publisher","unstructured":"Jamee M, Zaki-Dizaji M, Lo B, Abolhassani H, Aghamahdi F, Mosavian M, et al. Clinical, Immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome. J Allergy Clin Immunol Pract. 2020;8:2747\u20132760.e7. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.070. This article is a systematic review of patients with IPEX and IPEX-like syndrome to delineate differences in these 2 major groups. Also, it implies that HSCT is currently the only curative therapy for both IPEX and IPEX-like syndrome and may result in favorable outcome.","DOI":"10.1016\/j.jaip.2020.04.070"},{"key":"1026_CR8","doi-asserted-by":"publisher","first-page":"643094","DOI":"10.3389\/fped.2021.643094","volume":"9","author":"F Consonni","year":"2021","unstructured":"Consonni F, Ciullini Mannurita S, Gambineri E. Atypical presentations of IPEX: expect the unexpected. Front Pediatr. 2021;9:643094. https:\/\/doi.org\/10.3389\/fped.2021.643094.","journal-title":"Front Pediatr"},{"key":"1026_CR9","doi-asserted-by":"publisher","unstructured":"Monies D, Abouelhoda M, Assoum M, Moghrabi N, Rafiullah R, Almontashiri N, et al. Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet. 2019 Jun 6;104:1182\u2013201. https:\/\/doi.org\/10.1016\/j.ajhg.2019.04.011. Authors report the results of clinical exome sequencing on >2,200 previously unpublished Saudi families as a first-tier test. Authors\u2019 cohort's genotypic and phenotypic data represent a unique resource that can contribute to improved variant interpretation through data sharing.","DOI":"10.1016\/j.ajhg.2019.04.011"},{"key":"1026_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/ACI.0000000000000689","volume":"20","author":"A Chan","year":"2020","unstructured":"Chan A, Torgerson T. Primary immune regulatory disorders: a growing universe of immune dysregulation. Curr Opin Allergy Clin Immunol. 2020;20:582\u201390. https:\/\/doi.org\/10.1097\/ACI.0000000000000689.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1026_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fped.2016.00107","volume":"4","author":"A Mauracher","year":"2016","unstructured":"Mauracher A, Gujer E, Bachmann L, G\u00fcsewell S, Pachlopnik SJ. Patterns of Giardino G, Gallo V, Prencipe R, Gaudino G, Romano R, De Cataldis M, et al. Unbalanced immune system: immunodeficiencies and autoimmunity. Front Pediatr. 2016;4:107. https:\/\/doi.org\/10.3389\/fped.2016.00107.","journal-title":"Front Pediatr"},{"key":"1026_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaip.2020.10.057","volume":"9","author":"A Mauracher","year":"2021","unstructured":"Mauracher A, Gujer E, Bachmann L, G\u00fcsewell S, Pachlopnik SJ. Patterns of immune dysregulation in primary immunodeficiencies: a systematic review. J Allergy Clin Immunol Pract. 2021;9:792\u2013802.e10. https:\/\/doi.org\/10.1016\/j.jaip.2020.10.057.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1026_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3389\/fimmu.2020.01119","volume":"11","author":"M Massaad","year":"2020","unstructured":"Massaad M, Zainal M, Al-Herz W. Frequency and manifestations of autoimmunity among children registered in the Kuwait National Primary Immunodeficiency Registry. Front Immunol. 2020;11:1119. https:\/\/doi.org\/10.3389\/fimmu.2020.01119.","journal-title":"Front Immunol"},{"key":"1026_CR14","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00431-011-1588-1","volume":"170","author":"K Bae","year":"2011","unstructured":"Bae K, Kim B, Choi J, Lee J, Park Y, Kim G, et al. A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Eur J Pediatr. 2011;170:1611\u20135. https:\/\/doi.org\/10.1007\/s00431-011-1588-1.","journal-title":"Eur J Pediatr"},{"key":"1026_CR15","doi-asserted-by":"publisher","unstructured":"Gambineri E, Ciullini Mannurita S, Hagin D, Vignoli M, Anover-Sombke S, DeBoer S, et al. Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-Linked (IPEX) syndrome. Front Immunol. 2018;9:2411. https:\/\/doi.org\/10.3389\/fimmu.2018.02411. This article is a systematic review of patients with IPEX and IPEX-like syndrome to delineate differences in these 2 major groups. Also, it implies that HSCT is currently the only curative therapy for both IPEX and IPEX-like syndrome and may result in favorable outcome.","DOI":"10.3389\/fimmu.2018.02411"},{"key":"1026_CR16","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","volume":"19","author":"J Park","year":"2020","unstructured":"Park J, Lee K, Jeon B, Ochs H, Lee J, Gee H, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review. Autoimmun Rev. 2020;19:102526. https:\/\/doi.org\/10.1016\/j.autrev.2020.102526.","journal-title":"Autoimmun Rev"},{"key":"1026_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/art.38877","volume":"67","author":"S Wakil","year":"2015","unstructured":"Wakil S, Monies D, Abouelhoda M, Al-Tassan N, Al-Dusery H, Naim E, et al. Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheum. 2015;67:288\u201395. https:\/\/doi.org\/10.1002\/art.38877.","journal-title":"Arthritis Rheum"},{"key":"1026_CR18","first-page":"327","volume":"35","author":"SM Al-Mayouf","year":"2017","unstructured":"Al-Mayouf SM, Naji H, Alismail K, Alazami A, Sheikh F, Conca W, et al. Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis? Clin Exp Rheumatol. 2017;35:327\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1026_CR19","doi-asserted-by":"publisher","unstructured":"Mazzoni M, Dell'Orso G, Grossi A, Ceccherini I, Viola S, Terranova P, et al. Underlying CTLA4 deficiency in a patient with juvenile idiopathic arthritis and autoimmune lymphoproliferative syndrome features successfully treated with abatacept-A case report. J Pediatr Hematol Oncol. 2021. https:\/\/doi.org\/10.1097\/MPH.0000000000002120.","DOI":"10.1097\/MPH.0000000000002120"},{"key":"1026_CR20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/rheumatology\/kem129","volume":"46","author":"T Eastell","year":"2007","unstructured":"Eastell T, BSPAR Study Group, Hinks A, Thomson W. SNPs in the FOXP3 gene region show no association with Juvenile Idiopathic Arthritis in a UK Caucasian population. Rheumatology (Oxford). 2007;46:1263\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kem129.","journal-title":"Rheumatology (Oxford)"},{"key":"1026_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40272-019-00337-7","volume":"21","author":"M Bevacqua","year":"2019","unstructured":"Bevacqua M, Baldo F, Pastore S, Valencic E, Tommasini A, Maestro A, et al. Off-label use of sirolimus and everolimus in a pediatric center: a case series and review of the literature. Paediatr Drugs. 2019;21:185\u201393. https:\/\/doi.org\/10.1007\/s40272-019-00337-7.","journal-title":"Paediatr Drugs"},{"key":"1026_CR22","doi-asserted-by":"publisher","unstructured":"Barzaghi F, Amaya Hernandez L, Neven B, Ricci S, Kucuk Z, Bleesing J, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. J Allergy Clin Immunol. 2018;141:1036\u20131049.e5. https:\/\/doi.org\/10.1016\/j.jaci.2017.10.041. This analysis sought to evaluate disease onset, progression, and long-term outcome of the 2 main treatments (allogeneic hematopoietic stem cell transplantation and immunosuppression) in long-term IPEX survivors.","DOI":"10.1016\/j.jaci.2017.10.041"},{"key":"1026_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/pedi.12895","volume":"20","author":"T Yamauchi","year":"2019","unstructured":"Yamauchi T, Takasawa K, Kamiya T, Kirino S, Gau M, Inoue K, et al. Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome. Pediatr Diabetes. 2019;20:1035\u201340. https:\/\/doi.org\/10.1111\/pedi.12895.","journal-title":"Pediatr Diabetes"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-021-01026-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T14:40:14Z","timestamp":1626273614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-021-01026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1007\/s11926-021-01026-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"22 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee of the Research Affairs Council at KFSH-RC approved the study protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for genetic testing as part of patient care was obtained from the parents at the time of blood extraction.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"64"}}